These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7550531)

  • 1. Hypofibrinolysis and the insulin resistance syndrome.
    Vague P; Raccah D; Scelles V
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S11-5. PubMed ID: 7550531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofibrinolysis and insulin-resistance.
    Juhan-Vague I; Vague P
    Diabete Metab; 1991 May; 17(1 Pt 2):96-100. PubMed ID: 1936490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
    Juhan-Vague I; Alessi MC; Morange PE
    Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].
    Banfi C; Mussoni L; Tremoli E
    Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
    Mavri A; Alessi MC; Juhan-Vague I
    J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen-activator inhibitor type 1 and coronary artery disease.
    Kohler HP; Grant PJ
    N Engl J Med; 2000 Jun; 342(24):1792-801. PubMed ID: 10853003
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
    Carmassi F; De Negri F; Fioriti R; De Giorgi A; Giannarelli C; Fruzzetti F; Pedrinelli R; Dell'Omo G; Bersi C
    Thromb Res; 2005; 116(3):207-14. PubMed ID: 15935829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAI-1, obesity, insulin resistance and risk of cardiovascular events.
    Juhan-Vague I; Alessi MC
    Thromb Haemost; 1997 Jul; 78(1):656-60. PubMed ID: 9198234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat cell function and fibrinolysis.
    Alessi MC; Morange P; Juhan-Vague I
    Horm Metab Res; 2000; 32(11-12):504-8. PubMed ID: 11246816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.
    Juhan-Vague I; Alessi MC; Vague P
    Ann Med; 1996 Aug; 28(4):371-80. PubMed ID: 8862693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension as a metabolic disorder--an overview.
    Smith U; Gudbjörnsdottir S; Landin K
    J Intern Med Suppl; 1991; 735():1-7. PubMed ID: 2043218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
    Yudkin JS
    Diabetes Care; 1999 Apr; 22 Suppl 3():C25-30. PubMed ID: 10189559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
    Os I; Nordby G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S15-21. PubMed ID: 1283764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T; Hauner H
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.